Kentucky Administrative Regulations › Title 902 - CABINET FOR HEALTH AND FAMILY SERVICES - DEPARTMENT FOR PUBLIC HEALTH › Chapter 2 - Communicable Diseases › Section 902 KAR 2:065 - Immunization requirements for long-term care facilities

Current through Register Vol. 51, No. 1, July 1, 2024
RELATES TO:
				KRS
				209.550,
				209.552,
				211.090,
				211.180,
				214.010,
				216.510,
				216.515,
				216.530,
				42 C.F.R.
				483.80
NECESSITY, FUNCTION, AND CONFORMITY:
				KRS
				209.554(1) requires the
				Cabinet for Health and Family Services, Department for Public Health to
				promulgate administrative regulations to implement provisions of
				KRS
				209.550 to
				KRS
				209.554 relating to immunization of residents
				and employees of long-term care facilities against influenza and pneumococcal
				disease. This administrative regulation establishes requirements for long-term
				care facilities to request that residents and employees agree to be vaccinated
				against influenza and pneumococcal disease, to provide vaccine for the
				residents and employees or to make a referral for vaccination, to maintain
				annual documentation of immunizations, and to report outbreaks of influenzalike
				illnesses.
Section 1. Definitions.
(1) "Advisory Committee on Immunization
			 Practices" or "ACIP" means the United States Department of Health and Human
			 Services (HHS) Committee that makes national immunization recommendations to
			 the Secretary of HHS, the Assistant Secretary for Health, and the Director of
			 the Centers for Disease Control and Prevention (CDC).
(2) "Department" is defined by
			 KRS
			 209.550(2).
(3) "Employee" is defined by
			 KRS
			 209.550(4).
(4) "If vaccine is available" means that a
			 sufficient supply of vaccine has been produced by vaccine manufacturers and is
			 available for purchase and shipment.
(5) "Influenza" means an acute viral
			 infection of the respiratory tract:
(a)
			 Caused by an influenza virus;
(b)
			 Confirmed by:
1. Viral culture;
2. Polymerase chain reaction (PCR);
3. Nucleic acid detection testing;
			 or
4. Rapid influenza diagnostic
			 testing (RIDT); and
(c)
			 Characterized by the sudden onset of a group of signs and symptoms such as
			 fever, headache, myalgia, coryza, sore throat, and a dry cough.
(6) "Influenza-like illness" or
			 "ILI" means, in the absence of a known cause, other than influenza, an illness
			 in which a person experiences:
(a) Fever
			 greater than or equal to 100 degrees Fahrenheit or thirty seven and
			 eight-tenths (37.8) degrees Celsius, as confirmed through oral or equivalent
			 methods;
(b) Cough;
(c) Sore throat; or
(d) Cough and sore throat.
(7) "Influenza vaccine" means a
			 vaccine licensed by the Food and Drug Administration for the prevention of
			 influenza.
(8) "Immunize" means to
			 vaccinate.
(9) "Long-term care
			 facility" is defined by
			 KRS
			 209.550(6).
(10) "Medically indicated" means a vaccine is
			 recommended by the ACIP for a person:
(a) Who
			 has not been immunized against a disease; and
(b) For whom vaccination is recommended based
			 on:
1. The age of the person;
2. A preexisting medical condition that may
			 cause the person to be at risk; or
3. An occupation of the person that may put
			 others at risk of contracting the disease.
(11) "Outbreak" means two (2) or more cases
			 of influenza, or ILI, occurring in a single long-term care facility during a
			 seventy-two (72) hour period.
(12)
			 "Pneumococcal disease" means a bacterial infection usually involving the lungs
			 producing inflammation caused by Streptococcus pneumoniae, the bacteria
			 commonly referred to as "pneumococcus".
(13) "Pneumococcal vaccine" means a vaccine
			 licensed by the Food and Drug Administration for the prevention of
			 pneumococcus.